Share on StockTwits

Array BioPharma (NASDAQ:ARRY) will be releasing its Q414 earnings data on Tuesday, August 12th. Analysts expect Array BioPharma to post earnings of ($0.23) per share and revenue of $8.10 million for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Array BioPharma (NASDAQ:ARRY) opened at 4.01 on Monday. Array BioPharma has a one year low of $3.39 and a one year high of $6.66. The stock’s 50-day moving average is $4.17 and its 200-day moving average is $4.4. The company’s market cap is $505.2 million.

On a related note, analysts at Cantor Fitzgerald initiated coverage on shares of Array BioPharma in a research note on Thursday, May 29th. They set a “buy” rating and a $9.00 price target on the stock.

Array BioPharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.

Receive News & Ratings for Array BioPharma Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Array BioPharma Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.